Teladoc Health (NYSE:TDOC – Get Free Report) is scheduled to release its earnings data after the market closes on Thursday, April 25th. Analysts expect Teladoc Health to post earnings of ($0.47) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Teladoc Health (NYSE:TDOC – Get Free Report) last posted its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.05. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The company had revenue of $660.50 million for the quarter, compared to analyst estimates of $670.79 million. During the same quarter last year, the company earned ($0.23) earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Teladoc Health Stock Up 3.3 %
TDOC stock opened at $13.75 on Wednesday. The stock’s 50 day moving average is $15.31 and its 200-day moving average is $17.83. The firm has a market capitalization of $2.33 billion, a PE ratio of -10.26 and a beta of 0.94. Teladoc Health has a twelve month low of $12.85 and a twelve month high of $30.41. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66.
Insider Activity
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on TDOC. Citigroup dropped their price target on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Royal Bank of Canada dropped their price target on Teladoc Health from $30.00 to $25.00 and set an “outperform” rating on the stock in a report on Wednesday, February 21st. Barclays dropped their price target on Teladoc Health from $26.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, February 21st. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research note on Friday, April 5th. Finally, Leerink Partnrs restated a “market perform” rating on shares of Teladoc Health in a research note on Monday, February 26th. Eight analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $22.23.
Check Out Our Latest Stock Analysis on TDOC
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More
- Five stocks we like better than Teladoc Health
- What Are Dividend Challengers?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What Are Trending Stocks? Trending Stocks Explained
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Transportation Stocks Investing
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.